BRIDGEWATER, N.J. (AP) — BRIDGEWATER, N.J. (AP) — Amneal Pharmaceuticals, Inc. (AMRX) on Friday reported a loss of $31.1 million in its fourth quarter. The Bridgewater, New Jersey-based ...
GlobalData on MSN4 个月
Amneal files again for FDA approval of first dihydroergotamine autoinjectorAmneal Pharmaceuticals has submitted another new drug application (NDA) for its dihydroergotamine (DHE) prefilled syringe ...
In 2024, Amneal introduced a record number of new products, focusing on complex generics and biosimilars. The company’s ongoing investments in R&D and sales expansion aim to sustain long-term ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈